Active Awards Portfolio Dashboard
It takes a lot of effort to develop a promising stem cell research idea into an effective treatment that can help patients. CIRM funds a pipeline of projects spanning discovery, translation and clinical stage research. Check out our portfolio of active research awards in our interactive dashboard below. For a detailed list of CIRM-funded clinical trials, visit our Clinical Trials Dashboard.
Filter Awards
| Disease |
Cell Type |
Therapeutic or Technology | Institution | Stage | Project Objective | Details |
|---|---|---|---|---|---|---|
| HIV/AIDS | Personalized cell therapy | COH |
 |
IND | ||
| Osteonecrosis | Adult Stem Cell | Small molecule therapy | UC Davis |
 |
Clinical Trial, Phase 1 or Phase 1/2 | |
| Multiple Myeloma | Adult Stem Cell | Gene-modified, personalized cell therapy | Poseida Therapeutics |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Sarcoma | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
 |
Pre-IND/IDE or Equivalent | |
| Sickle Cell Disease | Adult Stem Cell | Donor cell therapy | COH |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Heart Disease, Danon Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
 |
Development Candidate, Proof of Concept | |
| Leukocyte Adhesion Deficiency | Adult Stem Cell | Gene-modified, personalized cell therapy | Rocket Pharmaceuticals, Inc. |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Hemophilia A | Adult Stem Cell | Gene modification | COH |
|
Development Candidate, Proof of Concept | |
| Severe Combined Immunodeficiency, Artemis deficient (ART-SCID) | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSF |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | UCLA |
|
Development Candidate, Proof of Concept | |
| Skeletal/Smooth Muscle disorders | Adult Stem Cell | Protein/peptide therapy | Stanford |
|
Research Insights | |
| Stroke | Adult Stem Cell | Gene-modified, donor cell therapy | SanBio, Inc. |
 |
Clinical Trial, Phase 2 | |
| Intestinal Disease | Adult Stem Cell | Personalized cell therapy | CHLA |
|
Development Candidate, Proof of Concept | |
|
B cell cancers, Leukemia |
Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Alpha Thalassemia Major | Adult Stem Cell | Donor cell therapy | UCSF |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Beta Thalassemia | Adult Stem Cell | Gene-modified, personalized cell therapy | Sangamo |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Blood Disorders, Blood Cancer |
Adult Stem Cell | Small molecule therapy | UCLA |
|
Development Candidate | |
| Bone or Cartilage Disease | Adult Stem Cell | Tissue engineering | Stanford |
|
Proof of Concept, Research Insights | |
| Autism | Adult Stem Cell | Gene-modified, donor cell therapy | UC Davis |
|
Development Candidate, Proof of Concept | |
|
Immune Disease, Severe Combined Immunodeficiency, Adenosine deaminase-deficient (ADA-SCID) |
Adult Stem Cell | Gene-modified, personalized cell therapy | Orchard Therapeutics |
|
Clinical Trial, Phase 2 | |
| Amyotrophic Lateral Sclerosis | Adult Stem Cell | Gene-modified, personalized cell therapy | BrainStorm |
 |
Clinical Trial, Phase 3 | |
| Other | Adult Stem Cell | Cell imaging & tracking | Stanford |
|
Tool/Resources/Bottleneck | |
| Blood Disorders | Adult Stem Cell | Cell processing & handling | UCSF |
|
Tool/Resources/Bottleneck | |
| Skeletal/Smooth Muscle disorders | Adult Stem Cell | Small molecule therapy | Stanford |
|
Development Candidate | |
| HIV/AIDS | Adult Stem Cell | Gene-modified, personalized cell therapy | CIT |
|
Proof of Concept | |
| Lung Cancer | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Cystic Fibrosis | Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
|
Development Candidate | |
| Blood Cancer | Adult Stem Cell | Gene-modified, donor cell therapy | Angiocrine |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Vascular Disease | Adult Stem Cell | Personalized cell therapy | UC Davis |
|
Proof of Concept | |
| Cystinosis | Adult Stem Cell | Gene-modified, personalized cell therapy | UCSD |
|
IND | |
| Bone or Cartilage Disease | Adult Stem Cell | Small molecule therapy | MAX BioPharma |
|
Pre-IND/IDE or Equivalent | |
|
Diabetic Wounds, Skin Disease |
Adult Stem Cell | Donor cell therapy | UC Davis |
|
Pre-IND/IDE or Equivalent | |
| Heart disease associated with Duchenne muscular dystrophy | Adult Stem Cell | Donor cell therapy | Capricor |
|
Clinical Trial, Phase 2 | |
| Kidney Failure | Adult Stem Cell | Biologic | Humacyte |
|
Clinical Trial, Phase 3 | |
| Corneal Damage | Adult Stem Cell | Personalized cell therapy | UCLA |
|
IND | |
| Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | Stanford |
|
IND | |
| Blood Disorders | Adult Stem Cell | Cell processing & handling | Stanford |
|
Research Insights | |
| Retinitis Pigmentosa | Adult Stem Cell | Donor cell therapy | jCyte |
|
Clinical Trial, Phase 2 | |
| Leukemia, Acute Myeloid (AML) | Adult Stem Cell | Donor cell therapy | Nohla Therapeutics |
|
Clinical Trial, Phase 2 | |
|
HIV-related Lymphoma, HIV/AIDS |
Adult Stem Cell | Gene-modified, personalized cell therapy | UC Davis |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Sickle Cell Disease | Adult Stem Cell | Gene-modified, personalized cell therapy | CHORI |
|
Pre-IND/IDE or Equivalent | |
|
Beta Thalassemia, Sickle Cell Disease |
Adult Stem Cell | Diagnostic Test | CHORI |
|
Regulated Lab Test, Ready for Validation | |
| Kidney Failure | Adult Stem Cell | Donor cell therapy | Stanford |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
| Hearing Loss | Adult Stem Cell | Protein/peptide therapy | Stanford |
|
Development Candidate, Proof of Concept | |
| Blood Disorders | Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
|
Development Candidate, Proof of Concept | |
| Blood Cancer | Adult Stem Cell | Donor cell therapy | Angiocrine |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Immune Disease, X-linked Chronic Granulomatous Disease |
Adult Stem Cell | Gene-modified, personalized cell therapy | UCLA |
|
Clinical Trial, Phase 1 or Phase 1/2 | |
|
Pulmonary Hypertension, Vascular Disease |
Adult Stem Cell | Donor cell therapy | Cedars-Sinai |
|
Clinical Trial, Phase 1 or Phase 1/2 |
Pages
